Your browser doesn't support javascript.
loading
Treatment patterns and costs among patients with OAB treated with combination oral therapy, sacral nerve stimulation, percutaneous tibial nerve stimulation, or onabotulinumtoxinA in the United States.
Kraus, Stephen R; Shiozawa, Aki; Szabo, Shelagh M; Qian, Christina; Rogula, Basia; Hairston, John.
Affiliation
  • Kraus SR; Department of Urology, University of Texas Health Sciences Center, San Antonio, Texas, San Antonio, Texas.
  • Shiozawa A; Medical Affairs, Astellas Pharma Global Development Inc, Northbrook, Illinois.
  • Szabo SM; Health Economics, Broadstreet HEOR, Vancouver, Canada.
  • Qian C; Health Economics, Broadstreet HEOR, Vancouver, Canada.
  • Rogula B; Health Economics, Broadstreet HEOR, Vancouver, Canada.
  • Hairston J; Medical Affairs, Astellas Pharma Global Development Inc, Northbrook, Illinois.
Neurourol Urodyn ; 39(8): 2206-2222, 2020 11.
Article in En | MEDLINE | ID: mdl-32827230

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thiazoles / Electric Stimulation Therapy / Muscarinic Antagonists / Botulinum Toxins, Type A / Urinary Bladder, Overactive / Acetanilides Type of study: Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Neurourol Urodyn Year: 2020 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thiazoles / Electric Stimulation Therapy / Muscarinic Antagonists / Botulinum Toxins, Type A / Urinary Bladder, Overactive / Acetanilides Type of study: Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Neurourol Urodyn Year: 2020 Document type: Article Country of publication: